Paraoxonase 1 192 and 55 polymorphisms in nephrotic children

Pediatric Nephrology

Volumn 21, Issue 5, 2006, Pages 649-654

  Biyikli, Nese Karaaslan ^a,d   Alpay, Harika ^a   Yildiz, Nurdan ^b   Agachan, Bedia ^c   Ergen, Arzu ^c   Zeybek, Umit ^c   Bozkurt, Nilufer ^c   Ispir, Turgay ^c  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SSK Goztepe Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Child; Nephrotic syndrome; Paraoxonase 1 192 polymorphism; Paraoxonase 1 55 polymorphism

Indexed keywords

ALBUMIN; ARYLDIALKYLPHOSPHATASE 1; CHLORAMBUCIL; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ALLELE; ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FISHER EXACT TEST; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ARYLDIALKYLPHOSPHATASE; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; NEPHROTIC SYNDROME; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TURKEY;

EID: 33646141857     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0073-y     Document Type: Article

References (20)

1. Niaduet P (2004) Steroid sensitive idiopathic nephrotic syndrome in children. In: Avner ED, Harmon WE, Niaduet P (eds) Pediatric nephrology. Lippincott Williams & Wilkins, Philadelphia, pp 543-556
2. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57-60
3. Ichikawa I, Fogo A (1996) Focal segmental glomerulosclerosis. Pediatr Nephrol 10:374-391
4. Guijarro C, Keane WF (1994) Lipid-induced glomerular injury. Nephron 67:1-6
5. Frisberg Y, Toledano H, Becker-Cohen R, Feigin E, Halle D (2000) Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis. Am J Kidney Dis 36:1253-1261
6. Horan MJ, Sinaiko AR (1987) Synopsis of the report of the Second Task Force on blood pressure control in children. Hypertension 10:115-121
7. Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 34:571-590
8. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM (1990) Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4:303-307
9. Mosby's Drug Consult (2005) MD consult core collection, 15th edn
10. Miller SA, Dykes DD, Polesky HS (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215
11. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73-76
12. Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598-608
13. Lewis CM (2002) Genetic association studies: Design, analysis and interpretation. Brief Bioinform 3:146-153
14. Merouani A, Levy E, Mongeau JG, Robitaille P, Lambert M, Devlin EE (2003) Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem 36:571-574
15. Ferroni P, Basili S, Falco A, Davi G (2004) Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal 6:747-756
16. Thabet MAEH, Salcedo JR, Chan JCM (1993) Hyperlipidemia in childhood nephrotic syndrome. Pediatr Nephrol 7:559-566
17. Keane WF, Kasiske BL, O'Donnell MP (1988) Lipids and progressive glomerulosclerosis: A model analogous to atherosclerosis. Am J Nephrol 8:261-271
18. Diamond JR (1991) Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39:S29-S34
19. Heinecke JW, Lusis AJ (1998) Paraoxonase-gene polymorphisms associated with coronary heart disease: Support for the oxidative damage hypothesis? Am J Hum Genet 62:20-24
20. Sanghera DK, Aston CE, Saha N, Kamboh MI (1998) DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet 62:36-44